Clinical Trial Update: Optimization of the Dosage Regimen of Growth Hormone Therapy in Children Born Small for Gestational Age [Phase 3]

View source ↗

Summary

Phase 3 trial updating the dosage regimen optimization for growth hormone therapy in children born small for gestational age.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Gestational Age

Drugs mentioned

• Growth hormone therapy (somatropin)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Small Gestational Age (SGA) | Phase 3 | Status: COMPLETED | Results posted: 2012-10-10